68
RemeGen Co. Ltd. Class A
688331.SS · SHH
¥114.75 +0.60% (+¥0.68)
1M -12.09%
Market Cap ¥70.4B
P/E Ratio 12.10x
Div. Yield -
ROE 128.12%
Bulios Fair Price
¥115.57
0.7% upside
Current Price
¥114.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 688331.SS is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
64 /100
Fair P/E 12.10x
EV/EBITDA 11.28x
P/S 8.79x
Growth
78 /100
Growing Rev. growth 61.48%
Book val. growth 10.18%
EPS growth N/A
Profitability
100 /100
Strong Gross margin 92.67%
Net margin 72.70%
Op. margin 61.01%
Quality
95 /100
Excellent ROIC 56.62%
ROE 128.12%
ROA 59.11%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 4.86x
Int. coverage 128.60x
Stability
31 /100
Unstable Beta 0.44x
Rev. volatility 24.82%
EPS volatility 101.73%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688331.SS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Min Fang
Employees
3,048
Headquarters
Yantai
Upcoming events
04 NOV
Earnings
Upcoming earnings report